Table 3:

Intraoperative and postoperative outcomes

	Patients receiving anti-aggregation (n = 38)	Propensity score-matched patients not receiving antiplatelet therapy (n = 141)	P
Total amount of chest tubes, ml ± SD (range)	340 ± 70 (220–470)	370 ± 110 (150–680)	0.2764
Redo thoracotomy for bleeding, n (%)	0	2 (1%)	0.3473
Average length of hospital stay, days (range)	4.3 (0–6)	5.5 (0–28)	0.2665
Postoperative surgical morbidity, n (%)	0	5 (4)	0.4563
Postoperative medical morbidity (including blood transfusions), n (%)	4 (11)	23 (16)	0.4414
Operative mortality, n (%)	0	2 (1)	0.3562